AU Stock MarketDetailed Quotes

MAP Microba Life Sciences Ltd

Watchlist

0.170
+0.005+3.03%

20min DelayNot Open Jul 22 12:55 AET

76.13MMarket Cap-4473P/E (Static)

Microba Life Sciences Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

Total revenue

15.60%5.42M

4.69M

Operating revenue

15.60%5.42M

--4.69M

Cost of revenue

18.04%2.74M

2.32M

Gross profit

13.21%2.68M

2.37M

Operating expense

22.91%22.91M

18.64M

Selling and administrative expenses

-6.71%8.5M

--9.11M

-Selling and marketing expense

28.11%692.71K

--540.71K

-General and administrative expense

-8.91%7.81M

--8.57M

Research and development costs

73.43%9.34M

--5.38M

Depreciation amortization depletion

6.41%1.64M

--1.54M

-Depreciation and amortization

6.41%1.64M

--1.54M

Other operating expenses

31.95%3.43M

--2.6M

Operating profit

-24.32%-20.23M

-16.27M

Net non-operating interest income (expenses)

14,349.51%817.64K

-5.74K

Non-operating interest income

1,672.01%878.05K

--49.55K

Non-operating interest expense

97.53%16.41K

--8.31K

Total other finance cost

-6.34%44K

--46.98K

Other net income (expenses)

39.89%6.74M

4.82M

Other non-operating income (expenses)

39.89%6.74M

--4.82M

Income before tax

-10.59%-12.67M

-11.46M

Income tax

-38.86%5.64K

9.23K

Earnings from equity interest net of tax

Net income

-10.55%-12.68M

-11.47M

Net income continuous operations

-10.55%-12.68M

---11.47M

Noncontrolling interests

Net income attributable to the company

-10.55%-12.68M

-11.47M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-10.55%-12.68M

-11.47M

Diluted earnings per share

21.60%-0.038

-0.0485

Basic earnings per share

21.60%-0.038

-0.0485

Dividend per share

Accounting Standards

US-GAAP

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022
Total revenue	15.60%5.42M	4.69M
Operating revenue	15.60%5.42M	--4.69M
Cost of revenue	18.04%2.74M	2.32M
Gross profit	13.21%2.68M	2.37M
Operating expense	22.91%22.91M	18.64M
Selling and administrative expenses	-6.71%8.5M	--9.11M
-Selling and marketing expense	28.11%692.71K	--540.71K
-General and administrative expense	-8.91%7.81M	--8.57M
Research and development costs	73.43%9.34M	--5.38M
Depreciation amortization depletion	6.41%1.64M	--1.54M
-Depreciation and amortization	6.41%1.64M	--1.54M
Other operating expenses	31.95%3.43M	--2.6M
Operating profit	-24.32%-20.23M	-16.27M
Net non-operating interest income (expenses)	14,349.51%817.64K	-5.74K
Non-operating interest income	1,672.01%878.05K	--49.55K
Non-operating interest expense	97.53%16.41K	--8.31K
Total other finance cost	-6.34%44K	--46.98K
Other net income (expenses)	39.89%6.74M	4.82M
Other non-operating income (expenses)	39.89%6.74M	--4.82M
Income before tax	-10.59%-12.67M	-11.46M
Income tax	-38.86%5.64K	9.23K
Earnings from equity interest net of tax
Net income	-10.55%-12.68M	-11.47M
Net income continuous operations	-10.55%-12.68M	---11.47M
Noncontrolling interests
Net income attributable to the company	-10.55%-12.68M	-11.47M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-10.55%-12.68M	-11.47M
Diluted earnings per share	21.60%-0.038	-0.0485
Basic earnings per share	21.60%-0.038	-0.0485
Dividend per share
Accounting Standards	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

AU

Overall